Antidote

Dimercaprol Injection

Rs 75 / Pack

Dose: 1ml-5ml
Injectable Form: Solution
Application: Analgesics and Pain Relief Medicines
Injection Site: Intravenous
Packaging Type: Glass Bottle

Our company has created niche in the medical industry, by offering well-formulated range of dimercaprol injection. It maintains the accurate ph value and ensures precise composition. It is a chelating agent and removes the metal poisoning from the blood.

It inhibits the reaction of metallic poison that may be gold, arsenic or any other harmful metal and gets secreted in the kidneys.
We offer injection with 50 mg strength capacity and should be consumed under the expert supervision of doctors as its overdose or exceeding measurable quality can cause adverse health problems to the patients.

Composition:	Each mL contains: dimercaprol USP: 50 mg, benzyl benzoate USP: 9.6% v/v, peanut oil USP: q s
Category:	Chelating agent for use in heavy metal poisoning
Method of action:	Dimercaprol chelates heavy metals e.g. arsenic, gold, mercury, lead as well as bismuth, nickel and thallium by competing with endogenous sulfhydryl groups on enzymes Absorption: peak plasma concentration after 30 to 60 min (IM) Distribution: to all tissues including the brain Metabolism: rapidly hepatic, converted to inactive metabolites. Excretion: urine and bile
Indication and usage:	Dimercaprol Injections is indicated in the treatment of acute poisoning by certain heavy metals, arsenic, gold, bismuth, antimony and possibly thallium. Although dimercaprol has not been successful in the treatment of lead poisoning when used alone, there is evidence that used in conjunction with sodium calcium edentate; it can be used successfully in the treatment of lead poisoning, particularly in children

Dosage administration:	Children: Dimercaprol Injections is well tolerated by children and the dosage should be calculated on the basis of bodyweight, using the same unit dose per Kg body weight as for an adult under similar clinical circumstances Adults: 400 to 800 mg, in divided doses, on the first day; 200 to 400 mg, in divided doses, on the second and third day; 100 to 200 mg, in divided doses, on the subsequent days. As a general guide, single doses should not be exceeded 3 mg/kg bodyweight. However, in severe acute poisoning, single doses up to 5 mg per kg bodyweight may be required initially Elderly: there is no specific data on the use of dimercaprol in the elderly but since it is eliminated via the kidney, it should be used with caution in the aged group

Adverse effect:	Hypertension, tachycardia, malaise, salvation, lacrimation, sweating, tingling of extremities, local pain and abscess at injection site, CNS stimulation, nausea, vomiting,

NAME OF PRODUCT : YASHICAPROL (DIMERCAPROL INJECTION USP 100MG/2ML)
TEST	SPECIFICATION AS PER USP
Description	A Slightly Yellow Colored Viscous Solution
Identification	Should Comply As Pr USP
Average Volume Of 10 Containers	NLT 2.0 ML
Nominal Volume	2.0 Ml
Color And Clarity	Should Be Slightly Yellow Colored Viscous Solution
Assay - Each ML Contains:	90.0% To 110.0%